Columbia Laboratories, Inc. (CBRX)

[keekee]

Prior to the NDA in April 2011, CBRX was trading between $3 - $4. Stock is worth way more than this joke on its own. Approval here, which would happen IMO, would take this towards $6. Approval is a certainty based on the fact that the Advisory Opinion only requested "additional" information only. We know that WPI has been meeting FDA officials for that additional information.

Take note that for the last reported qtr, revenues leaped by 103.7%, while industry average of 10.8%.

The debt-to-equity ratio of zero

In the last reported qtr, CBRX reported a 66% rise in the sales of Crinone overseas.

At the last reported qtr, Earnings Growth was about 366.66%

Overall, whether Prochieve is approved on 26th or later upon presentation of the "additional" facts, you are seeing a stock that ought to be above $2 without factoring in the PFV of the Prochieve application.

Do your DD, but the more I did, the more I bought until I can buy no more